Evidence map›Paper›PMID 14612417›Full record

ArticleMolecular and cellular biology2003

The murine G+C-rich promoter binding protein mGPBP is required for promoter-specific transcription.

Li-Chung Hsu, Shu Liu, Ferishteh Abedinpour, Robert D Beech, Jill M Lahti, Vincent J Kidd, Jeffrey A Greenspan, Cho-Yau Yeung

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Li-Chung HsuDepartment of Molecular Genetics, The University of Illinois at Chicago, Chicago, Illinois 60607, USA.
Shu Liu
Ferishteh Abedinpour
Robert D Beech
Jill M Lahti
Vincent J Kidd
Jeffrey A Greenspan
Cho-Yau Yeung
University of Illinois Chicago · USSt. Jude Children's Research Hospital · USUniversity of Saint Mary of the Lake · US

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI SUZANNE J. BAKER · 1985 to 2026
$166.9M
STRUCTURE/FUNCTION OF PITSLRE KINASESR01GM044088 · NIGMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LAHTI, JILL M · 1991 to 2010
$2.2M
INDUCTION AND SUPPRESSION OF ANGIOGENESISR44CA078044 · NCI · MUNIN CORPORATION · PI GREENSPAN, JEFFREY A · 2000 to 2002
$861k
Novel Anti-Angiogenic Drugs for Cancer TherapyR43CA091376 · NCI · MUNIN CORPORATION · PI GREENSPAN, JEFFREY A · 2001 to 2001
$299k
ANTI-ANGIOGENIC MIMETICS FOR CANCER THERAPYR43CA089777 · NCI · MUNIN CORPORATION · PI GREENSPAN, JEFFREY A · 2001 to 2001
$250k
REGULATION OF CYCLIN C FUNCTION IN TUMORS &NORMAL CELLSR29CA072572 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI LAHTI, JILL M · 1997 to 2001
$215k
INDUCTION AND SUPPRESSION OF NEOANGIOGENESISR43CA078044 · NCI · MUNIN CORPORATION · PI GREENSPAN, JEFFREY A · 1998 to 1998
–
BRIAN SPECIFIC AMYLOID PLAQUE FORMATIONR01AG011623 · NIA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI YEUNG, CHO-YAU · 1995 to 1999
–
NCI NIH HHS 5PO1 CA21765NCI NIH HHS CA72572NCI NIH HHS CA78044NCI NIH HHS CA89777NCI NIH HHS CA91376NCI NIH HHS P30 CA021765NIA NIH HHS AG11623NIGMS NIH HHS R01 GM044088NIGMS NIH HHS R01 GM44088
6 · The paper itself

Abstract

The archetypal TATA-box deficient G+C-rich promoter of the murine adenosine deaminase gene (Ada) requires a 48-bp minimal self-sufficient promoter element (MSPE) for function. This MSPE was used to isolate a novel full-length cDNA clone that encodes a 66-kDa murine G+C-rich promoter binding protein (mGPBP). The mGPBP mRNAs are ubiquitously expressed as either 3.0- or 3.5-kb forms differing in 3' polyadenylation site usage. Purified recombinant mGPBP, in the absence of any other mammalian cofactors, binds specifically to both the murine Ada gene promoter's MSPE and the nonhomologous human Topo IIalpha gene's G+C-rich promoter. In situ binding assays, immunoprecipitation, and Western blot analyses demonstrated that mGPBP is a nuclear factor that can form complexes with TATA-binding protein, TFIIB, TFIIF, RNA polymerase II, and P300/CBP both in vitro and in intact cells. In cotransfection assays, increased mGPBP expression transactivated the murine Ada gene's promoter. Sequestering of GPBP present in HeLa cell nuclear extract by immunoabsorption completely and reversibly suppressed extract-dependent in vitro transcription from the murine Ada gene's G+C-rich promoter. However, transcription from the human Topo IIalpha gene's TATA box-containing G+C-rich promoter was only partially suppressed and the adenovirus major late gene's classical TATA box-dependent promoter is totally unaffected under identical assay conditions. These results implicate GPBP as a requisite G+C-rich promoter-specific transcription factor and provide a mechanistic basis for distinguishing transcription initiated at a TATA box-deficient G+C-rich promoter from that initiated at a TATA box-dependent promoter.

Indexed as

Promoter Regions, GeneticAdenosine DeaminaseAnimalsAntigens, NeoplasmBase CompositionBase SequenceCloning, MolecularDNADNA-Binding ProteinsDNA Topoisomerases, Type IIHeLa CellsHumansIn Vitro TechniquesMiceMolecular Sequence DataNuclear ProteinsAdenosine DeaminaseAntigens, NeoplasmDNADNA-Binding ProteinsDNA Topoisomerases, Type IINuclear ProteinsRecombinant ProteinsRNA, Messenger

Identifiers

PMID14612417
PMCPMC262660
OpenAlexW2096476960

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.